Risk Stratification and Invasive Strategy in NSTE-ACS
نویسندگان
چکیده
Under the heading of acute coronary syndrome (ACS), we include myocardial infarction with ST segment elevation (STEMI), myocardial infarction without ST segment elevation (NSTEMI) and unstable angina (UA). Given the similar pathophysiological mechanisms, clinical manifestations, diagnostic and therapeutic algorithm UA and NSTEMI are sorted into a common group of ACS without ST segment elevation (NSTE-ACS). ACS is a serious clinical disease, which is associated with higher mortality than stable angina pectoris. High proportion of patients die of sudden death in the early hours of ACS (especially STEMI), before admission to the hospital, therefore it is difficult to assess the real incidence of ACS. The incidence of ACS also depends on the sensitivity of the humoral markers of myocyte necrosis. The annual hospital admissions rate for NSTE-ACS is estimated from the results of registers and surveys about 3 per 1000 inhabitants. The proportion of STEMI represents approximately 20% of NSTE ACS.
منابع مشابه
5-year clinical outcomes in the ICTUS (Invasive versus Conservative Treatment in Unstable coronary Syndromes) trial a randomized comparison of an early invasive versus selective invasive management in patients with non-ST-segment elevation acute coronary syndrome.
OBJECTIVES We present the 5-year clinical outcomes according to treatment strategy with additional risk stratification of the ICTUS (Invasive versus Conservative Treatment in Unstable coronary Syndromes) trial. BACKGROUND Long-term outcomes may be relevant to decide treatment strategy for patients presenting with non-ST-segment elevation acute coronary syndromes (NSTE-ACS) and elevated tropon...
متن کاملRisk stratification in non-ST elevation acute coronary syndromes: Risk scores, biomarkers and clinical judgment.
Undifferentiated chest pain is one of the most common reasons for emergency department attendance and admission to hospitals. Non-ST elevation acute coronary syndrome (NSTE-ACS) is an important cause of chest pain, and accurate diagnosis and risk stratification in the emergency department must be a clinical priority. In the future, the incidence of NSTE-ACS will rise further as higher sensitivi...
متن کاملWhen is the Best Time for the Second Antiplatelet Agent in Non-St Elevation Acute Coronary Syndrome?
Dual antiplatelet therapy is a well-established treatment in patients with non-ST elevation acute coronary syndrome (NSTE-ACS), with class I of recommendation (level of evidence A) in current national and international guidelines. Nonetheless, these guidelines are not precise or consensual regarding the best time to start the second antiplatelet agent. The evidences are conflicting, and after m...
متن کاملUtilization of early invasive management strategies for high-risk patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE Quality Improvement Initiative.
CONTEXT The American College of Cardiology/American Heart Association (ACC/AHA) guidelines for the management of non-ST-segment elevation acute coronary syndromes (NSTE ACS) recommend early invasive management for high-risk patients, given the benefits with this approach demonstrated in randomized clinical trials. OBJECTIVES To determine the use and predictors of early invasive management str...
متن کامل[Early invasive strategy in non-ST-segment elevation acute coronary syndrome. The paradox continues].
OBJECTIVE Observational studies have reported a paradoxical inverse relationship between the use of an early invasive strategy (EIS) and the risk of events in patients with non-ST-segment elevation acute coronary syndrome (NSTE ACS). The study objectives are: 1) to examine the association between baseline risk in patients with NSTE ACS and the use of EIS; and 2) to identify some of the factors ...
متن کامل